Additional file 12: Table S13. of Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators

KEGG pathways and DAVID clusters that are associated with genes preferentially up regulated (>1.33-fold) in GL261(scid) tumors treated with CPA/6d (Table S13A, B) or CPA/9d (Table S13C, D). Also shown (Table S13E) are KEGG pathways enriched in the set of genes expressed at a level 1.5-fold higher level in GL261(scid) tumors treated on the CPA/9d schedule than those treated on CPA/6d schedule. (XLSX 55 kb)